에 대한 최신 뉴스 Intuitive Surgical (NASDAQ:ISRG) 주식

INTUITIVE SURGICAL INC

Intuitive Surgical

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.

What Wedbush’s Dan Ives Said

Equities

News

Markets

DASH

ISRG

PLTR

S&amp;P 다우존스 인디시즈(S&amp;P Dow Jones Indices)는 금요일(7일)에 팔란티어 테크놀로지스(NASDAQ:PLTR)가 S&amp;P 100 지수에 합류한다고 발표했다. 데이터 분석 회사인 팔란티어의 주가는 선거 후 놀라운 상승세를 이어가고 있다.

팔란티어, 곧 S&amp;P 100 지수 합류...트럼프 당선 이후 주가 60% 급등

Chatbot,Conversation,Ai,Artificial,Intelligence,Technology,Online,Customer,Service.digital,Chatbot,

Commodities

AXON

CPNG

IDXX

MELI

PCAR

SPOT

케이티 허버티(Katy Huberty)는 모건 스탠리의 글로벌 리서치 책임자로, 인공지능(AI) 도입으로 인해 상당한 이점을 얻을 가능성이 있는 20개의 주식을 주목했다. 무슨 일이 있었나: 허버티는 현재 AI 도입을 위한 &#34;전환점&#34;에 있다고 언급했다. 그녀는 AI를 활용하여 수익을 증대시키는 기업들이 상당한 혜택을 누릴 준비가 되어 있다고 강조했다.

모건 스탠리, 인공지능 채택이 임계치에 도달함에 따라 상위 20개 AI 기반 주식 공개

Verizon Communications Inc. (VZ)

Earnings

Pre-Market Outlook

금요일(24일) 아침 미국 주식 선물이 소폭 하락하는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식들은 다음과 같다. 아메리칸 익스프레스, 보잉, 버라이즌, 인튜이티브 서지컬 및 HCA 헬스케어

금요일 주목해야 할 주식: 아메리칸 익스프레스, 보잉, 버라이즌, 인튜이티브 서지컬 및 HCA 헬스케어

Intuitive Surgical Inc

Intuitive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced the publication of two peer-reviewed studies in Surgical Endoscopy, on its first-of-its-kind Force Feedback technology incorporated in the da Vinci 5 surgical system.&nbsp;&nbsp;
Force Feedback technology allows surgeons to feel the forces applied to tissue during surgery, such as pushing and pulling. These studies - conducted in the pre-clinical setting using tissue models - demonstrate its potential to reduce the amount of force placed on tissue during surgery and enhance surgeon performance.
The first study, led by a team including Michael M. Awad MD, PhD, Professor of Surgery at Washington University School of Medicine in St. Louis, showed that using Force Feedback technology can lead to a reduction in force on tissue by up to 43 percent, irrespective of the surgeon's experience level. The study evaluated the forces applied to surgical models by 28 surgeons who had varying levels of experience when using Force Feedback technology during retraction, dissection, and suturing tasks.

Biotech

General

Intuitive Announces The Publication Of Two Peer-Reviewed Studies In Surgical Endoscopy, On Its Force Feedback Technology Incorporated In The Da Vinci 5 Surgical System

Deep-pocketed investors have adopted a bullish approach towards Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ISRG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Intuitive Surgical. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 11% bearish. Among these notable options, 3 are puts, totaling $101,684, and 6 are calls, amounting to $234,587.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $420.0 to $550.0 for Intuitive Surgical during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale trades within a strike price range from $420.0 to $550.0 in the last 30 days. 
<h3>Intuitive Surgical 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743009333_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$44.1</td>
<td>$41.7</td>
<td>$42.86</td>
<td>$530.00</td>
<td>$85.9K</td>
<td align="right">117</td>
<td align="right">20</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$34.8</td>
<td>$34.1</td>
<td>$34.8</td>
<td>$485.00</td>
<td>$38.2K</td>
<td align="right">62</td>
<td align="right">11</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$19.5</td>
<td>$17.1</td>
<td>$18.12</td>
<td>$520.00</td>
<td>$36.2K</td>
<td align="right">154</td>
<td align="right">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$48.4</td>
<td>$46.6</td>
<td>$47.6</td>
<td>$500.00</td>
<td>$33.3K</td>
<td align="right">355</td>
<td align="right">12</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$29.9</td>
<td>$29.2</td>
<td>$29.2</td>
<td>$520.00</td>
<td>$32.1K</td>
<td align="right">126</td>
<td align="right">12</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
In light of the recent options history for Intuitive Surgical, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Intuitive Surgical Standing Right Now?</h3>
<ul>
<li>With a volume of 939,608, the price of ISRG is down -2.07% at $509.05. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 27 days.</li>
</ul>
<h3>What Analysts Are Saying About Intuitive Surgical</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $602.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Intuitive Surgical with a target price of $605. 
&#x2A; An analyst from Baird persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $600. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Intuitive Surgical, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

What the Options Market Tells Us About Intuitive Surgical

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 5 years by 9.33% on an annualized basis producing an average annual return of 27.47%. Currently, Intuitive Surgical has a market capitalization of $173.59 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 5 years ago, it would be worth $395.27 today based on a price of $484.53 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742568308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Investors with a lot of money to spend have taken a bullish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 10%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $578,750, and 3 are calls, for a total amount of $332,362.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $430.0 to $560.0 for Intuitive Surgical over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Intuitive Surgical's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Intuitive Surgical's substantial trades, within a strike price spectrum from $430.0 to $560.0 over the preceding 30 days.
<h3>Intuitive Surgical Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742311859_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$38.2</td>
<td>$37.1</td>
<td>$37.1</td>
<td>$485.00</td>
<td>$278.2K</td>
<td align="right">15</td>
<td align="right">75</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$47.5</td>
<td>$46.1</td>
<td>$46.78</td>
<td>$490.00</td>
<td>$187.2K</td>
<td align="right">23</td>
<td align="right">40</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$16.2</td>
<td>$16.1</td>
<td>$16.1</td>
<td>$440.00</td>
<td>$94.9K</td>
<td align="right">251</td>
<td align="right">61</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$47.2</td>
<td>$46.3</td>
<td>$47.2</td>
<td>$490.00</td>
<td>$94.4K</td>
<td align="right">23</td>
<td align="right">40</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$68.2</td>
<td>$66.5</td>
<td>$68.2</td>
<td>$550.00</td>
<td>$68.2K</td>
<td align="right">18</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>Trading volume stands at 376,046, with ISRG's price down by -1.73%, positioned at $480.33.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Expert Opinions on Intuitive Surgical</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $602.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on Intuitive Surgical, which currently sits at a price target of $600. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Intuitive Surgical, targeting a price of $605. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Intuitive Surgical options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

This Is What Whales Are Betting On Intuitive Surgical

Baird analyst David Rescott maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and lowers the price target from $707 to $600.

Price Target

Analyst Ratings

Baird Maintains Outperform on Intuitive Surgical, Lowers Price Target to $600

Truist Securities analyst Richard Newitter maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and lowers the price target from $666 to $605.

Truist Securities Maintains Buy on Intuitive Surgical, Lowers Price Target to $605

Last week,&nbsp;U.S. President&nbsp;Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on&nbsp;<a target="_blank" href="https://www.benzinga.com/news/global/25/02/44010093/trumps-plan-for-canada-mexico-china-tariffs-to-start-march-4-could-shake-stock-market" rel="noreferrer noopener">those from China to 20%</a>.
China responded to Trump&#8217;s recent tariff hikes by placing its own tariffs on certain U.S. goods, sanctioning American companies, and planning to file a complaint with&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/25/03/44117288/after-china-mexico-to-hit-back-against-trumps-tariffs-raising-trade-war-risks" rel="noreferrer noopener">the World Trade Organization</a>.
China also banned imports of <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">genetic sequencers</a> from&nbsp;Illumina Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43706143/why-is-ge-healthcare-stock-trading-higher-on-thursday" rel="noreferrer noopener">Why Is GE HealthCare Stock Trading Soaring On Thursday?</a>
Goldman Sachs has grown more confident that end markets are stabilizing and set for a recovery in 2025, despite ongoing policy and tariff uncertainties. Rising demand and increased stimulus are helping ease market bottlenecks.
Following a visit to China, Goldman Sachs analysts see capital equipment markets at a turning point and write that innovation remains a key advantage.
They are also optimistic about GE Healthcare Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) and Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) in the region.
While Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) offers unique technology, economic constraints, and national quotas may limit its growth. Meanwhile, local competition is expanding quickly, but Goldman Sachs sees limited impact due to a lack of technological differentiation. As a result, analyst David Roman upgraded GE Healthcare stock from Neutral to Buy, raising the <a target="_blank" href="https://editorial.benzinga.com/wp-admin/post.php?post=819159&amp;action=edit" rel="noreferrer noopener">price target from $85 to $100</a>.
The analyst has a balanced view on GE Healthcare with stable 4-5% growth in the base business (ex-China), offset by sustained headwinds in the China business (~14% of sales), which would yield top-line growth below consensus and the company&#8217;s medium targets of 4-6% organic revenue growth.
The forecast increase is due to stabilizing trends in China. The analyst expects China sales to return to 2023 levels by 2026, unlike the previous forecast, which did not anticipate a rebound through 2028.
Price Action: GEHC stock is up 0.45% at $85.74&nbsp;at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44251506/inuvo-is-better-aligned-with-consumer-demand-for-privacy-new-regulations-analyst" target="_blank" rel="noreferrer noopener">Inuvo Is Better Aligned With Consumer Demand For Privacy, New Regulations: Analyst</a></li>
</ul>
Photo by PixelBiss via Shutterstock

Analyst Color

Large Cap

Upgrades

Health Care

GEHC

ILMN

Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes

Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) will join the S&amp;P 100 index, S&amp;P Dow Jones Indices announced Friday, as the data analytics firm continues its remarkable post-election rally.
What Happened: &#8220;Palantir is proud to be admitted into the S&amp;P 100. Onwards,&#8221; the company stated Sunday on X.
The Denver-based company will replace Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) in the index effective Mar. 24, coinciding with the quarterly rebalance. Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) and ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) will also join the S&amp;P 100, replacing The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>).
Palantir has emerged as the top-performing S&amp;P 500 stock since President Donald Trump&#8216;s November election victory, surging nearly 60% to $84.82. This represents an annualized return exceeding 184%, <a href="https://www.benzinga.com/news/large-cap/25/03/44202991/best-and-worst-performing-sp-500-stocks-since-trumps-election-win">according to Benzinga Pro data</a>.
Market analysts attribute Palantir&#8217;s meteoric rise to its artificial intelligence capabilities and CEO Alex Karp&#8216;s support for <a href="https://www.benzinga.com/news/large-cap/25/03/44202991/best-and-worst-performing-sp-500-stocks-since-trumps-election-win">government efficiency initiatives</a>. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Palantir is proud to be admitted into the S&amp;P 100. Onwards. <a href="https://t.co/WxwfObpIUG">pic.twitter.com/WxwfObpIUG</a>
&mdash; Palantir (@PalantirTech) <a href="https://twitter.com/PalantirTech/status/1898888631944630768?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44212386/stock-futures-drop-as-reverse-trump-trade-takes-holdpeter-schiff-says-market-shift-long-overdue-and-will-likely-continue-for-a-decade">Stock Futures Drop As &#8216;Reverse Trump Trade&#8217; Takes Hold—Peter Schiff Says Market Shift &#8216;Long Overdue&#8217; And Will Likely Continue For A Decade</a>
Why It Matters: Recent analyst assessments present a mixed outlook. While the <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings">consensus price target</a> stands at $70.30 among 25 analysts, the three most recent ratings from Wedbush, Loop Capital, and Citigroup average $123.67, implying a potential upside of nearly 46%.
Other significant S&amp;P index changes announced include DoorDash Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) joining the S&amp;P 500, while FMC Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) and Celanese Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) — among the worst performers since Trump&#8217;s election — will be moved to the S&amp;P SmallCap 600.
Price Action: Palantir closed at $84.90 on Friday, up 5.52% for the day, before dipping 0.09% to $84.82 in after-hours trading. Year to date, the stock has gained 12.92%, while it has surged 234.92% over the past year. Although the stock is down 38% from its all-time high of $124.62 reached on Feb. 18, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44212672/jamie-dimon-cashed-out-234-million-in-jpmorgan-stock-warren-buffett-stockpiled-334-billion-in-cash-weeks-later-markets-crashed-coincidence">Jamie Dimon Cashed Out $234 Million In JPMorgan Stock, Warren Buffett Stockpiled $334 Billion In Cash — Weeks Later, Markets Crashed. Coincidence?</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Palantir Joins S&P 100 After AI-Driven Rally, Stock Surges Almost 60% Since Trump Victory

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 20 years by 18.43% on an annualized basis producing an average annual return of 26.62%. Currently, Intuitive Surgical has a market capitalization of $200.68 billion. 
Buying $1000 In ISRG: If an investor had bought $1000 of ISRG stock 20 years ago, it would be worth $117,740.76 today based on a price of $562.67 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741118412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

NXST

TOST

CNBC Halftime Report Final Trades: Toast, Nexstar Media Group, Salesforce, Intuitive Surgical

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 10 years by 15.24% on an annualized basis producing an average annual return of 26.48%. Currently, Intuitive Surgical has a market capitalization of $212.41 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 10 years ago, it would be worth $1,045.11 today based on a price of $595.55 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739568608_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today

Investors with a lot of money to spend have taken a bullish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 37%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $182,470, and 6 are calls, for a total amount of $760,472.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $540.0 to $660.0 for Intuitive Surgical over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Intuitive Surgical options trades today is 163.12 with a total volume of 549.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuitive Surgical's big money trades within a strike price range of $540.0 to $660.0 over the last 30 days.
<h3>Intuitive Surgical Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739560529_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$32.1</td>
<td>$28.9</td>
<td>$28.9</td>
<td>$590.00</td>
<td>$289.0K</td>
<td align="right">158</td>
<td align="right">100</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$53.7</td>
<td>$52.8</td>
<td>$53.7</td>
<td>$590.00</td>
<td>$268.5K</td>
<td align="right">72</td>
<td align="right">54</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$33.8</td>
<td>$33.7</td>
<td>$33.7</td>
<td>$540.00</td>
<td>$155.0K</td>
<td align="right">169</td>
<td align="right">47</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$96.0</td>
<td>$92.9</td>
<td>$92.9</td>
<td>$660.00</td>
<td>$120.7K</td>
<td align="right">81</td>
<td align="right">24</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$150.2</td>
<td>$145.3</td>
<td>$148.36</td>
<td>$550.00</td>
<td>$29.6K</td>
<td align="right">24</td>
<td align="right">2</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Intuitive Surgical's Current Market Status</h3>
<ul>
<li>With a volume of 637,780, the price of ISRG is up 0.55% at $594.63. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 62 days.</li>
</ul>
<h3>Professional Analyst Ratings for Intuitive Surgical</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $682.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Truist Securities persists with their Buy rating on Intuitive Surgical, maintaining a target price of $666. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Intuitive Surgical, targeting a price of $675. 
&#x2A; Consistent in their evaluation, an analyst from Raymond James keeps a Outperform rating on Intuitive Surgical with a target price of $688. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $711. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Overweight with a new price target of $670.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Intuitive Surgical options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Behind the Scenes of Intuitive Surgical's Latest Options Trends

Investors with a lot of money to spend have taken a bullish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 11 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 45% bullish and 36%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $326,170, and 8 are calls, for a total amount of $573,816.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $335.0 to $620.0 for Intuitive Surgical during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $335.0 to $620.0 in the last 30 days. 
<h3>Intuitive Surgical Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739388630_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$173.5</td>
<td>$167.5</td>
<td>$170.2</td>
<td>$460.00</td>
<td>$238.2K</td>
<td align="right">0</td>
<td align="right">57</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$43.5</td>
<td>$41.4</td>
<td>$42.0</td>
<td>$500.00</td>
<td>$210.0K</td>
<td align="right">5</td>
<td align="right">51</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$98.7</td>
<td>$94.6</td>
<td>$98.8</td>
<td>$590.00</td>
<td>$98.7K</td>
<td align="right">37</td>
<td align="right">9</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$24.5</td>
<td>$22.1</td>
<td>$23.8</td>
<td>$575.00</td>
<td>$95.2K</td>
<td align="right">227</td>
<td align="right">42</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$44.0</td>
<td>$43.0</td>
<td>$43.0</td>
<td>$500.00</td>
<td>$86.0K</td>
<td align="right">5</td>
<td align="right">91</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Intuitive Surgical's Current Market Status</h3>
<ul>
<li>Trading volume stands at 489,081, with ISRG's price down by -0.45%, positioned at $589.0.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 64 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $681.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $670. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $666. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $711. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Intuitive Surgical, which currently sits at a price target of $687. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Intuitive Surgical with a target price of $675. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Intuitive Surgical, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Intuitive Surgical

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 10 years by 15.36% on an annualized basis producing an average annual return of 26.62%. Currently, Intuitive Surgical has a market capitalization of $209.84 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 10 years ago, it would be worth $1,056.33 today based on a price of $588.37 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738767608_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 10 Years

Investors with a lot of money to spend have taken a bearish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 17 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 47%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $85,945, and 15 are calls, for a total amount of $773,230.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $450.0 and $670.0 for Intuitive Surgical, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $450.0 to $670.0 in the last 30 days. 
<h3>Intuitive Surgical Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738602936_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$40.2</td>
<td>$37.8</td>
<td>$38.9</td>
<td>$565.00</td>
<td>$155.6K</td>
<td align="right">38</td>
<td align="right">41</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$55.2</td>
<td>$54.5</td>
<td>$54.5</td>
<td>$560.00</td>
<td>$76.3K</td>
<td align="right">175</td>
<td align="right">14</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$34.2</td>
<td>$33.7</td>
<td>$33.7</td>
<td>$565.00</td>
<td>$67.4K</td>
<td align="right">38</td>
<td align="right">20</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$34.0</td>
<td>$32.7</td>
<td>$32.7</td>
<td>$565.00</td>
<td>$65.4K</td>
<td align="right">38</td>
<td align="right">41</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$29.7</td>
<td>$27.5</td>
<td>$28.6</td>
<td>$570.00</td>
<td>$57.2K</td>
<td align="right">381</td>
<td align="right">70</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
In light of the recent options history for Intuitive Surgical, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>Currently trading with a volume of 820,079, the ISRG's price is up by 1.69%, now at $581.55. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 73 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $684.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Intuitive Surgical, targeting a price of $687. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Intuitive Surgical, targeting a price of $711. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $670. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $666. 
&#x2A; An analyst from Raymond James has decided to maintain their Outperform rating on Intuitive Surgical, which currently sits at a price target of $688. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Rumors

Watching Intuitive Surgical; Shares See Volume, Traders Circulate Unconfirmed Rumor Co Wins Ongoing Repair Company Trail; $7B Hospital Class Action Remains Pending

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$25.00</td>
<td>$35.5K</td>
<td>6.0K</td>
<td>2.1K</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$150.00</td>
<td>$66.4K</td>
<td>7.2K</td>
<td>1.7K</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$55.00</td>
<td>$42.0K</td>
<td>3.0K</td>
<td>1.2K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$27.50</td>
<td>$109.6K</td>
<td>31.8K</td>
<td>1.1K</td>
</tr>
<tr>
<td>INMB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$10.00</td>
<td>$25.5K</td>
<td>2.1K</td>
<td>486</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$590.00</td>
<td>$45.0K</td>
<td>291</td>
<td>275</td>
</tr>
<tr>
<td>VKTX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$30.00</td>
<td>$34.0K</td>
<td>567</td>
<td>261</td>
</tr>
<tr>
<td>SWTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$35.00</td>
<td>$25.4K</td>
<td>511</td>
<td>220</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$62.50</td>
<td>$44.9K</td>
<td>137</td>
<td>189</td>
</tr>
<tr>
<td>BAX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$35.00</td>
<td>$36.8K</td>
<td>68</td>
<td>160</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TEVA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>), we observe a call option trade with bearish sentiment. It expires in 354 day(s) on January 16, 2026. Parties traded 163 contract(s) at a $25.00 strike. The total cost received by the writing party (or parties) was $35.5K, with a price of $218.0 per contract. There were 6058 open contracts at this strike prior to today, and today 2167 contract(s) were bought and sold. 
• For JNJ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), we notice a call option sweep that happens to be bearish, expiring in 25 day(s) on February 21, 2025. This event was a transfer of 200 contract(s) at a $150.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $66.4K, with a price of $336.0 per contract. There were 7225 open contracts at this strike prior to today, and today 1758 contract(s) were bought and sold. 
• Regarding CVS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), we observe a put option trade with bearish sentiment. It expires in 25 day(s) on February 21, 2025. Parties traded 200 contract(s) at a $55.00 strike. The total cost received by the writing party (or parties) was $42.0K, with a price of $210.0 per contract. There were 3069 open contracts at this strike prior to today, and today 1262 contract(s) were bought and sold. 
• For PFE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), we notice a call option sweep that happens to be bearish, expiring in 354 day(s) on January 16, 2026. This event was a transfer of 522 contract(s) at a $27.50 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $109.6K, with a price of $210.0 per contract. There were 31825 open contracts at this strike prior to today, and today 1191 contract(s) were bought and sold. 
• For INMB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>), we notice a call option sweep that happens to be bullish, expiring in 235 day(s) on September 19, 2025. This event was a transfer of 75 contract(s) at a $10.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $25.5K, with a price of $340.0 per contract. There were 2116 open contracts at this strike prior to today, and today 486 contract(s) were bought and sold. 
• Regarding ISRG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), we observe a call option sweep with bearish sentiment. It expires in 4 day(s) on January 31, 2025. Parties traded 200 contract(s) at a $590.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $45.0K, with a price of $225.0 per contract. There were 291 open contracts at this strike prior to today, and today 275 contract(s) were bought and sold. 
• For VKTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>), we notice a put option sweep that happens to be bullish, expiring in 25 day(s) on February 21, 2025. This event was a transfer of 252 contract(s) at a $30.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $34.0K, with a price of $135.0 per contract. There were 567 open contracts at this strike prior to today, and today 261 contract(s) were bought and sold. 
• For SWTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>), we notice a call option trade that happens to be bearish, expiring in 25 day(s) on February 21, 2025. This event was a transfer of 50 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $25.4K, with a price of $510.0 per contract. There were 511 open contracts at this strike prior to today, and today 220 contract(s) were bought and sold. 
• For BMY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>), we notice a put option sweep that happens to be bearish, expiring in 53 day(s) on March 21, 2025. This event was a transfer of 156 contract(s) at a $62.50 strike. This particular put needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $44.9K, with a price of $288.0 per contract. There were 137 open contracts at this strike prior to today, and today 189 contract(s) were bought and sold. 
• For BAX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAX#NYSE">BAX</a>), we notice a call option trade that happens to be bullish, expiring in 718 day(s) on January 15, 2027. This event was a transfer of 80 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $36.8K, with a price of $460.0 per contract. There were 68 open contracts at this strike prior to today, and today 160 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INMB

SWTX

TEVA

VKTX

10 Health Care Stocks With Whale Alerts In Today's Session

Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).
What Happened: Huberty expressed that we are currently at a &#8220;tipping point&#8221; for AI adoption. She underscored that businesses utilizing AI to boost their profits are on the verge of reaping considerable benefits.
Speaking <a href="https://www.businessinsider.com/ai-adopters-stocks-to-buy-beneficiaries-pricing-power-morgan-stanley-2025-1#home-depot-1">with</a> Business Insider earlier this month, Huberty pointed out that businesses with strong pricing power, those capable of maintaining or increasing their prices due to high demand, will witness the most significant impact on their profits. 
&#8220;Pricing power will allow the&nbsp;companies to retain the productivity&nbsp;that they experience on the&nbsp;back of these investments and&nbsp;not have to pass that&nbsp;on to the customer,&#8221; she elaborated.
Also Read: <a href="https://www.benzinga.com/markets/25/01/43216975/fund-manager-stanley-druckenmiller-delivers-blunt-take-on-markets-after-trumps-return-in-terms-of-markets-i-would-say-its-complicated">Fund Manager Stanley Druckenmiller Delivers Blunt Take On Markets After Trump&#8217;s Return: &#8216;In Terms of Markets, I Would Say It&#8217;s Complicated&#8217;</a>
Huberty referred&nbsp;to a list of stocks&nbsp;her team assembled in client&nbsp;note. The stocks, all AI adopters with high pricing power, have&nbsp;market caps over $20 billion.&nbsp;The list comprises&nbsp;The Home Depot, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>),&nbsp;Thermo Fisher Scientific Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), and&nbsp;Intuitive Surgical, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), Deere &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>), MercadoLibre Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), Marriott International Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>), Hilton Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>), PACCAR Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>), Schlumberger NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>), Johnson Controls International PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>), Axon Enterprise Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>), Coupang Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>), Baker Hughes Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Experian PLC, Delta Air Lines Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), IDEXX Laboratories Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>), United Airlines Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UA#NASDAQ">UA</a>), Halliburton Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>), among others.
Why It Matters: The adoption of AI has been a hot topic in recent years, with many industries recognizing its potential to transform business operations and drive profitability. 
Huberty&#8217;s identification of these 20 stocks underscores the growing importance of AI in the business landscape. Companies that successfully leverage AI technologies stand to gain a competitive edge, particularly those with strong pricing power. 
This development could signal a shift in investment strategies, with investors potentially looking to companies with strong AI adoption as promising opportunities.
Read Next
<a href="https://www.benzinga.com/markets/25/01/43217038/aoc-says-democrats-in-congress-are-doing-insider-trading-people-think-that-everyday-people-are-stupid">AOC Says Democrats in Congress Are Doing Insider Trading: &#8216;People Think That Everyday People Are Stupid&#8217;</a>
Image: Shutterstock

Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass

Wall Street paused for a breather on Friday, with the S&amp;P 500 index hovering around the flatline at midday trading in New York after a five-day rally that pushed the market to fresh record highs this week. Meanwhile, investor attention shifted to <a href="https://www.benzinga.com/markets/forex">forex and gold markets.</a>
The greenback is experiencing its worst weekly performance since July 2023, as President Donald Trump refrained from imposing new tariffs during his first week and escalated pressure on the Federal Reserve, urging the central bank to lower interest rates. The U.S. dollar index – tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – dropped 0.7% on Friday, extending its weekly decline to 1.7%.
Adding to the dollar's downward momentum, the Bank of Japan raised interest rates by 25 basis points to 0.5%, the highest level since 2008, in a move that broadly met expectations.
Gold capitalized on the dollar's weakness and rising tensions between the president and the central bank, marking another week of strong gains and approaching all-time highs. The bullion, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), was trading at $2,777 per ounce.
On the macro front, S&amp;P Global reported a slowdown in private sector growth in January, as the services sector faced an unexpected setback, despite manufacturing expanding for the first<a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43195427/us-services-growth-slows-manufacturing-finally-expands-in-january-inflation-was-broad-based-expert-warns"> time in seven months.</a>
A warning came from the University of Michigan's consumer survey, which downwardly revised the January consumer confidence indicator and pointed to increasing trends of households making purchases in advance to avoid potential price hikes <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43197024/consumer-confidence-declines-as-buying-in-advance-trends-grow">linked to tariffs.</a>
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed 2.5% following Trump's executive order signed on Thursday, aimed at strengthening U.S. leadership in digital assets. 
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,314.96</td>
<td>0.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,119.65</td>
<td>0.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,541.76</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,861.02</td>
<td>-0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) eased 0.1% to $608.89.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% lower to $444.96.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) slipped 0.4% to $530.73.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) stalled at $229.40.</li>
<li>The&nbsp;Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, up 0.9%; the&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.4%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) fell 2.4% after reporting fourth-quarter results. </li>
<li>Other stocks moving on quarterly results were Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), up 1.3%, NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>), up 4%, HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), down 3.2%, First Citizens BancShares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>), up 3.1%, Ericsson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIC#NASDAQ">ERIC</a>), down 14.3%, Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), down 3.6%, Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), down 7.1%, and CSX Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>), down 2.8%. </li>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) soared 8.1% after new weight loss drug amycretin showed strong trial results. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43198272/us-stocks-hit-dot-com-era-valuations-vs-bonds-why-some-experts-remain-bullish">US Stocks Hit Dot-Com Era Valuations Vs. Bonds: Why Some Experts Remain Bullish</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Specialty ETFs

Forex

Econ #s

Economics

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ERIC

FCNCA

PowerShares DB US Dollar Index Bullish Fund

Stocks Stall, Gold Nears Record Highs As Dollar Faces Worst Week Since July 2023: What's Driving Markets Friday?

Truist Securities analyst Richard Newitter maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $640 to $666.

Truist Securities Maintains Buy on Intuitive Surgical, Raises Price Target to $666

Press Releases

Meta-analysis published in Annals of Surgery shows benefits of da Vinci surgery across seven oncologic procedures compared to laparoscopic and open

Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics

Management

Intuitive Announces Executive Leadership Changes to Support Continued Global Growth

Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results

Intuitive Announces Plans to Establish Direct Presence in Italy, Spain, Portugal

Intuitive Announces Fourth Quarter Earnings

Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education

Astera Labs Appoints Dr. Craig Barratt to Board of Directors

Mutual Funds

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Peer-Reviewed Studies on Intuitive's Force Feedback Technology Demonstrate its Potential to Reduce Force on Tissue and Enhance Surgeon Performance

ALAB

AMBC

BBWI

CLSK

FLGT

FRPT

GDOT

GPRE

HAIN

HIMS

KTOS

MATV

MBOT

NEOG

SATS

SPGI

Abbott Laboratories

Baxter Intl

Becton, Dickinson and Company Common Stock

Becton Dickinson

Boston Scientific Corporation Common Stock

Boston Scientific

DexCom

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Techs

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

IDEXX Laboratories

Inspire Medical Systems, Inc. Common Stock

Inspire Medical Systems

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Integer Holdings Corporation Common Stock

Integer Holdings

Masimo

Medtronic

Penumbra

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips

Insulet

ResMed

Smith & Nephew

Steris

Stryker

Teleflex

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings

Baird

Truist Securities

Raymond James

Piper Sandler

Wells Fargo

Untitled design - 2024-12-10T185819.364

Movers & Shakers

S&amp;P 다우존스 인디시즈(S&amp;P Dow Jones Indices)는 금요일(7일)에 팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)가 S&amp;P 100 지수에 합류한다고 발표했다. 데이터 분석 회사인 팔란티어의 주가는 선거 후 놀라운 상승세를 이어가고 있다.
무슨 일 있었나: 팔란티어는 &#8220;S&amp;P 100에 편입된 것을 자랑스럽게 생각한다&#8221;고 일요일(9일)에 밝혔다.
덴버에 본사를 둔 팔란티어는 분기별 리밸런싱에 맞춰 3월 24일부터 다우(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)를 대체할 예정이다. 인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>)과 서비스나우(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>)도 S&amp;P 100 지수에 편입되며, 이들은 크래프트 하인즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>)와 포드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)를 대체한다.
팔란티어는 도널드 트럼프 대통령의 11월 대선 승리 이후 60% 가까이 급등한 84.82달러를 기록하며 S&amp;P 500 주식 중 최고 수익률을 나타냈다. 팔란티어의 지난 1년간 주가 상승률은 무려 234.95%에 이른다.
시장 애널리스트들은 팔란티어의 급격한 상승을 인공지능(AI) 역량과 알렉스 카프 CEO의 <a href="https://www.benzinga.com/news/large-cap/25/03/44202991/best-and-worst-performing-sp-500-stocks-since-trumps-election-win" target="_blank" rel="noopener">정부 효율성 이니셔티브</a>에 대한 지원 덕분으로 보고 있다.
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Palantir is proud to be admitted into the S&amp;P 100.
Onwards. <a href="https://t.co/WxwfObpIUG">pic.twitter.com/WxwfObpIUG</a>
&mdash; Palantir (@PalantirTech) <a href="https://twitter.com/PalantirTech/status/1898888631944630768?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
왜 중요한가: 최근 애널리스트들의 평가는 엇갈린 전망을 제시하고 있다. 25명의 애널리스트가 제시한 <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings" target="_blank" rel="noopener">목표주가 컨센서스</a>는 70.30달러인 반면, 웨드부시 루프 캐피탈, 씨티그룹의 가장 최근 평가는 평균 123.67달러로 약 46%의 잠재적 상승 여력이 있음을 시사한다.
또한 S&amp;P 지수의 다른 중요한 변화로는 도어대시(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>)가 S&amp;P 500에 포함되고, FMC(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)와 셀라니즈 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)은 트럼프 선거 이후 최악의 실적을 기록한 주식 중 하나로 S&amp;P SmallCap 600 지수로 이동된다.
주가 움직임: 팔란티어는 금요일에 5.52% 상승한 84.90달러로 마감한 후 시간외 거래에서 0.09% 하락한 84.82달러로 마감했다. 현재까지 주가는 12.93% 상승했으며, 지난 1년 동안 234.95% 급등했다. 팔란티어 주가는 2월 18일에 기록한 사상 최고가인 124.62달러 대비 38% 하락한 상태다.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter">
<div class="wp-block-embed__wrapper"></div>
</figure>
이미지 출처: Shutterstock
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 생성되었으며, Benzinga 편집자가 검토하고 게시했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

팔란티어, 곧 S&P 100 지수 합류...트럼프 당선 이후 주가 60% 급등

케이티 허버티(Katy Huberty)는 모건 스탠리의 글로벌 리서치 책임자로, 인공지능(AI) 도입으로 인해 상당한 이점을 얻을 가능성이 있는 20개의 주식을 주목했다.
무슨 일이 있었나: 허버티는 현재 AI 도입을 위한 &#8220;전환점&#8221;에 있다고 언급했다. 그녀는 AI를 활용하여 수익을 증대시키는 기업들이 상당한 혜택을 누릴 준비가 되어 있다고 강조했다.
허버티는 이번 달 초 <a href="https://www.businessinsider.com/ai-adopters-stocks-to-buy-beneficiaries-pricing-power-morgan-stanley-2025-1#home-depot-1">비즈니스 인사이더</a>와의 인터뷰에서 강력한 가격 결정력을 가진 기업, 즉 높은 수요로 인해 가격을 유지하거나 인상할 수 있는 기업들이 가장 큰 수익성 향상을 경험할 것이라고 지적했다.
그녀는 &#8220;가격 결정력은 기업들이 이러한 투자로 인한 생산성 향상을 고객에게 전가하지 않고 유지할 수 있게 해 줄 것&#8221;이라고 설명했다.
또한, 허버티는 그녀의 팀이 고객 노트에서 작성한 주식 목록을 언급했다. 이 주식들은 모두 AI를 도입하고 높은 가격 결정력을 가진 기업들로, 시가총액이 200억 달러 이상이다. 목록에는 홈디포(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), 써모 피셔 사이언티픽(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), 인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), 디어 앤 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), 스포티파이 테크놀로지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>), 메르카도리브레(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), 메리어트 인터내셔널(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>), 힐튼 월드와이드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>), 파카(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>), 슐럼버거 NV(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>), 존슨 컨트롤스 인터내셔널 PLC(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>), 엑슨 엔터프라이즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>), 쿠팡(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>), 베이커 휴즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), 익스피리언 PLC, 델타 항공(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), 아이덱스 래버러토리스(NASDAQ:<a class="ticker" style="font-size: revert;" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>), 유나이티드 에어라인 홀딩스(NASDAQ:<a class="ticker" style="font-size: revert;" href="https://www.benzinga.com/stock/UA#NASDAQ">UA</a>) 및 할리버튼(NYSE:<a class="ticker" style="font-size: revert;" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) 등이 포함되어 있다.
왜 중요한가요: AI 도입은 최근 몇 년간 뜨거운 주제가 되었으며, 많은 산업에서 비즈니스 운영을 혁신하고 수익성을 높일 수 있는 잠재력을 인식하고 있다.
허버티가 이러한 20개 주식을 지적한 것은 비즈니스 환경에서 AI의 중요성이 커지고 있음을 강조한다. AI 기술을 성공적으로 활용하는 기업들은 경쟁 우위를 얻을 수 있으며, 특히 강력한 가격 결정력을 가진 기업들이 그렇다.
이러한 발전은 투자 전략의 변화를 시사할 수 있으며, 투자자들이 강력한 AI 도입을 가진 기업들을 유망한 투자 기회로 보게 될 가능성이 있다.
다음 읽을거리:
<a href="https://www.benzinga.com/markets/25/01/43217038/aoc-says-democrats-in-congress-are-doing-insider-trading-people-think-that-everyday-people-are-stupid">AOC, &#8220;의회 민주당원들이 내부자 거래를 하고 있다&#8221;: &#8216;사람들은 일반 사람들이 바보라고 생각한다&#8217;</a>
이미지: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

금요일(24일) 아침 미국 주식 선물이 소폭 하락하는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식들은 다음과 같다.
<ul>
<li>아메리칸 익스프레스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>): 오늘 개장 전 실적을 발표할 예정이며, 171억 6천만 달러의 매출과 3.04달러의 주당순이익이 예상된다. 주가는 시간외 거래에서 0.3 % 상승한 326.99달러를 기록했다.</li>
<li>보잉(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>): 목요일(23일) 장 마감 후 4분기 예비 실적을 발표했다. IAM 작업 중단 및 계약, 특정 국방, 우주 및 보안 프로그램에 대한 비용, 작년부터 인력 감축과 관련된 비용과 관련된 분기 실적에 영향을 미칠 것이라고 밝혔다. 결과적으로 보잉의 4분기 매출은 152억 달러로 예상치 162억 7,000만 달러에 비해 감소할 것으로 예상된다. 또한 4분기 주당 5.46달러의 손실이 예상되고 있다. 주가는 시간외 거래에서 1.8% 하락한 175.25달러를 기록했다.</li>
<li>버라이즌 커뮤니케이션스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>): 오늘 개장 전 실적을 발표할 예정이며 353억 2천만 달러의 매출에 주당 1.10달러의 분기 순익을 기록할 것으로 예상된다. 주가는 시간외 거래에서 0.3% 상승한 39.30달러를 기록했다.</li>
</ul>
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 커버리지</a>를 확인하세요.
<ul>
<li>인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>): 목요일 장 마감 후 4분기 예상보다 나은 수익과 판매 실적을 발표했다. 2025년 연간 전 세계 다빈치 로봇 시술 건수가 약 13%~16% 증가할 것으로 예상한다고 밝혔다. 시간외 거래 세션에서 주가는 2.2% 하락한 595.00달러를 기록했다.</li>
<li>HCA 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>): 오늘 개장 전 실적을 발표할 예정이며 182억 3천만 달러의 매출에 주당 6.13달러의 분기 순익을 기록할 것으로 예상된다. 주가는 시간외 거래에서 1.9% 상승한 331.40달러를 기록했다.</li>
</ul>
사진 출처: Shutterstock
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/economy/%ED%8A%B8%EB%9F%BC%ED%94%84-%EA%B4%80%EC%84%B8%EB%8A%94-%EC%96%B4%EB%96%BB%EA%B2%8C%EB%93%A0-%EC%A7%80%EB%8A%94-%EA%B2%8C%EC%9E%84-%EA%B3%A8%EB%93%9C%EB%A7%8C%EC%82%AD%EC%8A%A4-%EA%B4%80/" target="_blank" rel="noopener">트럼프 관세는 &#8216;어떻게든 지는 게임&#8217;? 골드만삭스 &#8220;관세 부과와 보복 관세로 시장 하락할 것&#8221;</a>
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

로봇 보조 수술 회사 인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>)은 목요일(23일) 장 마감 후 4분기 재무 실적을 발표했다. 이번 <a href="https://www.benzinga.com/pressreleases/25/01/g43176400/intuitive-announces-fourth-quarter-earnings" target="_blank" rel="noopener">분기의 주요 실적은 다음과 같다.</a>
4분기 실적: 인튜이티브 서지컬의 4분기 매출은 24억 1,000만 달러로 <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noopener">컨센서스 예상치</a> 22억 5,000만 달러를 상회했다. <a href=""http://pro.benzinga.com/"">벤징가 프로에</a> 따르면 4분기 조정 주당순이익은 주당 2.21달러로 애널리스트 예상치 주당 1.79달러를 상회했다.
매출은 전년 동기 대비 25% 증가했다. 전 세계 다빈치 로봇 시술 건수는 전년 대비 약 18% 증가했다. 해당 분기에 493대의 다빈치 수술 시스템을 배치했으며, 전년 동기에는 415대를 배치했다고 밝혔다. 4분기 배치에는 174대의 &#8216;다빈치 5&#8217; 시스템이 포함되었다. 인튜이티브 서지컬의 다빈치 수술 시스템 설치 대수는 12월 31일 기준 총 9,902대로 전년 동기 대비 15% 증가했다.
해당 분기는 5억 2,100만 달러 증가한 88억 3,000만 달러의 현금, 현금 등가물 및 투자로 마감했다.
전망: 인튜이티브 서지컬은 2025년 연간 전 세계 다빈치 시술 건수가 약 13%에서 16% 증가할 것으로 예상한다. 회사는 2025년 매출 총이익률이 순 매출의 67%에서 68% 사이가 될 것으로 예상하고 있다.
게리 굿하트(Gary Guthart) 인튜이티브 CEO는 이렇게 말했다. "우리는 이번 분기 및 연간 동안 고객들이 다빈치 5, 이온, SP를 채택한 것에 만족한다. 환자 결과 개선을 중심으로 고객과 공유하는 목표를 달성하는 데 계속 집중하고 있다.&#8221;
주가 움직임: 인튜이티브 서지컬 주가는 목요일 시간외 거래에서 2.21% 하락한 595.20달러에 거래되었다.
사진: 인튜이티브 서지컬 제공
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

After-Hours Center

Movers

인튜이티브 서지컬 4분기 실적: 매출·주당순이익 예상치 상회, 다빈치 로봇 수술 증가율 18% 등

목요일(23일) 미국 주식은 상승세를 보였다. 다우존스 지수는 0.9% 상승하여 44,565.07포인트로 마감했고, 나스닥 지수는 0.2% 상승한 20,053.68포인트, S&amp;P 500는 0.5% 상승한 6,118.71포인트로 마감했다.
목요일에 소매 투자자들과 트레이더들의 관심을 끈 주요 종목은 다음과 같다.
<h3>1. 보잉 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>)</h3>
목요일 보잉 주가는 2.12% 상승하여 178.50달러에 마감했다. 장중 최고가 178.67달러, 최저가 173.75달러를 기록했으며, 52주 범위는 137.03~217.59달러다. 보잉은 <a href="https://www.benzinga.com/news/earnings/25/01/43179806/boeing-stock-falls-on-preliminary-q4-results-the-details" target="_blank" rel="noopener">4분기 매출이</a> 152억 달러로 예상치인 162억 7천만 달러를 하회할 것으로 예상하고 4분기 주당 5.46달러의 손실을 예상한다고 발표했다.
<h3>2. 니콜라 코퍼레이션 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>)</h3>
니콜라의 주가는 27.78% 급락하여 0.85달러로 마감했다. 장중 최고가는 1.17달러, 최저가는 0.76달러였고, 52주 신저가를 기록했다. 니콜라는 <a href="https://www.benzinga.com/news/earnings/25/01/43179806/boeing-stock-falls-on-preliminary-q4-results-the-details" target="_blank" rel="noopener">몇 주 동안 침묵을</a> 지키며 생산 및 배송 수치를 제출하지 않았다.
<h3>3. 텍사스 인스트루먼트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>)</h3>
텍사스 인스트루먼트는 1.81% 상승하여 200.61달러에 마감했다. 장중 최고가는 200.64 달러, 최저가는 193.81달러였고, 52주 범위는 155.46~220.39달러다. 텍사스 인스트루먼트는 <a href="https://www.benzinga.com/news/earnings/25/01/43179806/boeing-stock-falls-on-preliminary-q4-results-the-details" target="_blank" rel="noopener">4분기</a> 주당 1.30달러의 수익을 발표하여 애널리스트 컨센서스 예상치인 1.20달러를 상회했다.
<h3>4. 인튜이티브 서지컬 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>)</h3>
인튜이티브 서지컬의 주가는 0.29% 소폭 하락하여 608.66달러에 마감했다. 장중 최고가는 616달러, 최저가는 602달러이며, 52주 범위는 362.14~616달러다. 인튜이티브의 4분기 매출은 24억 1천만 달러로 <a href="https://www.benzinga.com/news/earnings/25/01/43179806/boeing-stock-falls-on-preliminary-q4-results-the-details" target="_blank" rel="noopener">컨센서스 예상치</a> 22억 5천만 달러를 상회한 것으로 나타났다.
<h3>5. 테슬라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</h3>
테슬라의 주가는 2.11% 하락하여 415.11달러로 마감했다. 장중 최고가는 428달러, 최저가는 414.59달러였고, 52주 범위는 138.80~488.54달러다. 새로운 보고서에 따르면 일론 머스크 CEO의 정치적 추진력이 테슬라의 브랜드 가치를 떨어뜨렸을 수 있다.
이미지 출처: Shutterstock
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/2024%EB%85%84-%ED%85%8C%EC%8A%AC%EB%9D%BC-%EB%B8%8C%EB%9E%9C%EB%93%9C-%EA%B0%80%EC%B9%98-150%EC%96%B5-%EB%8B%AC%EB%9F%AC-%EA%B0%90%EC%86%8C-%EB%A8%B8%EC%8A%A4%ED%81%AC%EC%9D%98-%EC%A0%95%EC%B9%98/" target="_blank" rel="noopener">2024년 테슬라 브랜드 가치, 150억 달러 감소: 머스크의 정치적 노력이 부정적 영향 미쳤을까?</a>
벤징가의 <a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">프리마켓 주요 주식 및 뉴스</a>로 하루의 거래를 준비하세요.
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 사용하여 생성되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal">Shivdeep Dhaliwal</a>이 편집했습니다.
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

NKLA

TSLA

목요일 주목받은 주식: 보잉, 니콜라, 텍사스 인스트루먼트, 인튜이티브 서지컬 및 테슬라

수요일(15일) 미국 증시는 나스닥 종합지수가 2.45% 상승한 19,511.23포인트 S&amp;P 500 지수가 1.8% 상승한 5,949.91포인트를 기록하며 강세를 보였다. 다우존스 산업평균지수도 1.65% 상승한 43,221.55포인트를 기록했다.
하루 종일 소매 투자자와 트레이더의 주목을 받은 상위 종목은 다음과 같다.
<h3>1. 퀀텀 컴퓨팅 </h3>
수요일 퀀텀 컴퓨팅 주가는 55.45% 급등하여 11.55달러로 마감했다. 장중 최고가는 11.60달러, 최저가는 8.51달러였고, 52주 범위는 27.15~0.35달러였다.
이러한 급등은 3월 20일로 예정된 GTC 2025 행사에서 <a href="https://www.benzinga.com/25/01/43004816/whats-going-on-with-quantum-computing-stock-today">엔비디아의 첫 번째 &#8216;퀀텀 데이&#8217; 발표</a> 이후 나왔다. 이번 발표는 젠슨 황 CEO가 실용적인 양자 컴퓨팅은 아직 20년이 더 걸릴 수 있다고 언급한 직후에 이루어진 것이다. 또한 2025년까지 비즈니스 고객을 &#8216;퀀텀 레디&#8217;로 만들겠다는 마이크로소프트의 계획이 발표되어 기대감을 더했다.
<h3>2. TSMC</h3>
TSMC 주가는 2.61% 상승하여 206.80달러로 마감했다. 이날 거래는 최고가 209.04달러, 최저가 199.35달러이며, 52주 범위는 222.20~100달러였다.
TSMC는 곧 4분기 재무 실적을 발표할 예정이며, 애널리스트들은 5분기 연속 매출 상향을 예상하고 있다. 예상 매출은 262억 8,000만 달러로, 반도체 수요 강세와 미국 새로운 행정부의 <a href="https://www.benzinga.com/25/01/43015316/taiwan-semiconductor-q4-earnings-preview-analysts-expect-fifth-straight-beat-will-investors-get-comments-on-trump-impact">잠재적 수혜</a>에 힘입어 작년 같은 분기의 196억 2,000만 달러보다 증가할 것으로 예상된다.
<h3>3. 메타 플랫폼스</h3>
메타 플랫폼스 주가는 3.85% 상승하여 617.12달러에 마감했다. 장중 최고가 622.46달러, 최저가 606.50달러를 기록했으며, 52주 범위는 638.40~358.61달러였다.
내부 메모에 따르면 <a href="https://www.benzinga.com/media/25/01/42995912/meta-plans-to-cut-5-of-staff-backfill-roles-in-2025-says-internal-memo">성과 기반 감원 계획이</a> 공개되었으며, 이러한 전략에는 지난 1년간의 기여도에 따라 직원을 성과 등급으로 분류하는 것이 포함된다.
<h3>4. 인튜이티브 서지컬</h3>
인튜이티브 서지컬의 주가는 7.65% 상승하여 580.11달러에 마감했다. 장중 최고가 584.60달러, 최저가 549.17달러를 기록했으며, 52주 범위는 584.60~355.17달러였다.
이번 주가 상승은 인튜이티브 서지컬의 <a href="https://www.benzinga.com/news/earnings/25/01/43007218/why-intuitive-surgical-shares-are-surging-wednesday">4분기 예비 실적에</a> 따른 것으로, 예상 매출은 약 24억 1천만 달러로 애널리스트의 예상치인 22억 달러를 상회하는 것으로 나타났다. 또한 다빈치 로봇 시술(da Vinci procedure)과 시스템 배치가 크게 증가했다고 보고했다.
<h3>5. 테슬라</h3>
테슬라의 주가는 8.04% 상승하여 428.22로 마감했다. 이날 거래의 최고가는 429.80달러, 최저가는 405.66달러였고, 52주 범위는 488.54~138.80달러였다.
이러한 상승세는 최근 켈리블루북이 발표한 데이터에서 테슬라의 모델 Y와 모델 3가 가장 많이 팔린 전기자동차로 선정된 데 영향을 받았다. 2023년에 비해 2024년에 경쟁 심화로 인해 약 37,000대의 자동차를 덜 판매했음에도 불구하고 테슬라는 전기차 시장에서 <a href="https://www.benzinga.com/25/01/43014719/whats-going-on-with-tesla-shares-wednesday">선두를 유지했다</a>.
이미지 출처: Shutterstock
<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">주요 프리마켓 주식 및 뉴스</a>를 벤징가에서 확인하고 하루의 거래를 준비하세요.
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 사용하여 생성되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal">Shivdeep Dhaliwal</a>이 편집했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

QUBT

수요일 주목받은 주식: 퀀텀 컴퓨팅, TSMC, 메타, 인튜이티브 및 테슬라

미국의 경쟁력은 2025년에 네 가지 주요 투자 테마인 에너지 독립, 방산 혁신, 인프라 및 자동화가 포트폴리오 성장을 강화할 태세를 갖추면서 중심 무대로 떠오른다. 스콧 헬프스타인(Scott Helfstein)이 이끄는 글로벌 X의 2025년 투자 전망은 이러한 변혁적인 트렌드를 <a href="https://www.benzinga.com/topic/us-economy" target="_blank" rel="noopener">향후 1년 동안</a>의 회복력의 중요한 동력으로 강조하고 있다.
<h2 class="wp-block-heading">인프라가 빛을 발산</h2>
미국의 인프라 르네상스가 본격화되면서 7,000억 달러의 지출이 건설, 장비 및 자재 회사에 활력을 불어넣을 예정이다. 이는 산업 선별 섹터 SPDR 펀드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)에 투자하는 투자자에게 긍정적인 신호가 될 수 있다.
구경제의 강자들은 매력적인 밸류에이션으로 S&amp;P 500 전반에 비해 거래되면서 마진을 확대하기 위해 최첨단 기술로 재편되고 있다.
<h2 class="wp-block-heading">방산 분야: 전투기와 함정을 넘어서</h2>
글로벌 긴장이 전통적인 방산 플랫폼에서 인공지능(AI) 기반 드론과 사이버 보안 시스템과 같은 첨단 솔루션으로의 전환을 촉발하고 있다.
팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) 인공지능 플랫폼과 IBM(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) 왓슨X AI가 여기에 해당한다.
방산 매출은 거의 10% 증가할 것으로 예상되며, 마진은 5.2%에서 7.6%로 상승할 것이다. 성공은 자동화와 차세대 기술을 채택하는 기업들에게 유리할 것이다.
참고: <a href="https://kr.benzinga.com/news/usa/stocks/%EC%A0%9C%EC%A1%B0%EC%97%85-%EB%B6%80%ED%99%9C-%EC%A0%84%EB%9E%B5%EA%B0%80-%EA%B4%80%EC%84%B8%EA%B0%80-%EC%86%8C%ED%98%95%EC%A3%BC%EC%97%90-%EB%8F%84%EC%9B%80%EC%9D%B4-%EB%90%98%EC%A7%80%EB%A7%8C/" target="_blank" rel="noopener">제조업의 재기? 전략가가 관세가 소형주에 도움을 줄 것이라고 예상하지만 소비자에게는 부담을 줄 것이라고 예상</a>
<h2 class="wp-block-heading">자동화 및 온쇼어링: 기술 혁명</h2>
미국이 온쇼어링 노력을 가속화함에 따라 자동화와 AI가 이 변화를 주도하는 핵심 요소로 부상하고 있다.
소프트웨어 회사들과 데이터 센터는 매출 급증을 준비하고 있으며, 메가 캡 기술 기업들은 데이터 센터에 대한 지출을 2025년까지 2,500억 달러로 늘리고 있다.
로봇 공학 및 IoT 하드웨어도 판매 정체에서 반등할 수 있어 자동화 부문은 주목할 만한 분야가 될 것이다. 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), 인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), ABB(OTC:<a class="ticker" href="https://www.benzinga.com/stock/ABBNY#OTC">ABBNY</a>), 로크웰 오토메이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>), 지브라 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>), 테라다인(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) 및 유아이패스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>)와 같은 회사들이 여기에 해당한다.
<h2 class="wp-block-heading">에너지 독립: 원자력으로 간다</h2>
에너지의 다음 경계는 무엇일까? 원자력이다. 메가 캡 기술 기업들이 모듈형 원자로를 친환경적이고 신뢰할 수 있는 전력원으로 주목하면서 우라늄 수요가 급증하고 있다. 미국을 넘어 일본과 독일과 같은 국가들도 원자력으로 전환하고 있어 에너지 회복력으로의 글로벌 전환을 알리고 있다.
콘스텔레이션 에너지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>), 카메코(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) 및 누스케일 파워(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>)와 같은 미국 기업들이 떠오르고 있다.
헬프스타인의 로드맵은 목표 지향적인 전략의 한 해를 제안한다. 이러한 미국 중심의 테마와 포트폴리오를 정렬함으로써 투자자들은 변동성을 견뎌낼 뿐만 아니라 혼란 속에서 번창할 수 있을 것이다.

다음 읽기: 
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%B2%84%ED%81%AC%EC%85%94%EC%99%80-%ED%8C%94%EB%9E%80%ED%8B%B0%EC%96%B4-etf%EB%93%A4-%EB%94%94%EB%A0%89%EC%8B%9C%EC%98%A8-%EC%B6%9C%EC%8B%9C%EB%A1%9C-%EA%B0%95%EB%A0%A5%ED%95%9C-%EA%B1%B0%EB%9E%98/" target="_blank" rel="noopener">버크셔, 팔란티어 ETF에 고옥탄 거래 옵션 추가</a></li>
</ul>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Long Ideas

Tech

ABBNY

NVDA

PATH

ZBRA

2025 투자 테마: 인공지능, 에너지 및 방산이 미국 시장을 재정의

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga's Stock Whisper Index)'는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">표면 바로 아래에서 주목</a>을 받을 만한 주식 5종목을 소개한다.
투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.
다음은 11월 8일 주간 벤징가 ‘스톡 위스퍼' 지수의 개요:
인스메드 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>):
이 생명공학 회사는 10월 말에 3분기 재무 결과와 사업 업데이트를 <a href="https://investor.insmed.com/2024-10-31-Insmed-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Update" target="_blank" rel="noopener">발표</a>한 후 투자자들의 관심이 증가하고 있다. 이 회사는 아리케이스(ARIKAYCE)의 매출이 3분기에 9,340만 달러로 전년 대비 18% 증가했다고 밝혔다.
인스메드는 또한 기관지 확장증 치료제 브렌소카팁(Brensocatib)에 대한 NDA 제출이 4분기에 예정되어 있으며, 2025년 중반에 미국에서 출시될 것으로 예상된다고 밝혔다.
H.C. 웨인라이트는 분기 실적 발표 후 주식에 대해 매수 등급과 90달러의 목표 주가를 재확인했다. 트루이스트(Truist)는 매수 등급을 재확인하고 목표 주가를 100달러에서 105달러로 상향 조정했다. 이 회사는 11월 11일에 구겐하임(Guggenheim), 11월 12일 UBS 글로벌, 11월 20일 울프 리서치(Wolfe Research) 및 11월 21일 제프리스(Jefferies)를 포함한 여러 컨퍼런스에 참여할 예정이어서 앞으로 몇 주 안에 투자자들의 관심이 증가할 수 있다.
인스메드 주식은 최근 5일 거래일 동안 9% 이상 상승했으며, 2024년 연초 대비 145% 이상 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135456/Screenshot-234.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
어플라이드 인더스트리얼 테크놀로지스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>):
이 산업 회사는 도널드 트럼프가 <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election" target="_blank" rel="noopener">2024년 선거</a>에서 승리하는 것과 관련이 있을 수 있는 독자들의 강한 관심을 본 분야의 여러 회사 중 하나였다. 산업 섹터는 트럼프 대통령의 백악관 <a href="https://www.benzinga.com/general/politics/24/11/41783357/how-did-s-p-500-sectors-perform-during-trumps-first-term-could-this-time-be-different" target="_blank" rel="noopener">재임 4년 동안</a> 최고 실적을 거둔 부문이었다.
또한 이 회사는 최근 1분기 재무 결과를 <a href="https://ir.applied.com/news/news-details/2024/Applied-Industrial-Technologies-Reports-Fiscal-2025-First-Quarter-Results/default.aspx" target="_blank" rel="noopener">발표</a>하여 주당 순이익이 2.36달러 그리고 매출이 11억 달러로, 스트리트 컨센서스 추정치인 22억 7천만 달러와 10억 9천만 달러를 각각 넘어섰다. 어플라이드 인더스트리얼은 또한 2025 회계연도 주당 이익 지침을 이전 지침인 9.20~9.95달러에서 9.25~10.00달러 범위로 상향 조정했다. 이는 월가의 추정치인 9.39달러보다 앞선 것이다.
이 분기 실적 발표 후 애널리스트들은 <a href="https://www.benzinga.com/quote/AIT/analyst-ratings" target="_blank" rel="noopener">목표 주가를 상향</a> 조정했다. 주식은 최근 5일 거래일 동안 16% 이상 상승했으며, 2024년 연초 대비 57% 이상 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135510/Screenshot-236.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
스프라우츠 파머스 마켓 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>):
이 전문 식료품 소매업체는 벤징가 독자들 사이에서 강한 관심을 받았으며, 이는 <a href="https://investors.sprouts.com/news/news-details/2024/Sprouts-Farmers-Market-Inc.-Reports-Third-Quarter-2024-Results/default.aspx" target="_blank" rel="noopener">최근</a> 분기 실적 발표 후 주가가 52주 최고가로 거래되고 있는 것과 관련이 있다. 이 회사의 3분기 주당 순이익은 91센트와 매출 19억 달러로 스트리트 예상치인 주당 76센트와 18억 8천만 달러를 각각 웃돌았다.
이 회사는 3분기가 예외적이었다고 언급했으며, CEO 잭 싱클레어(Jack Sinclair)는 &#8220;견고한 방문객 성장&#8221;을 강조했다. 동일 매장 매출이 3분기 동안 8.4% 증가했다. 이 회사는 9개의 새로운 매장을 열어 23개 주에 428개의 매장을 운영하고 있다.
골드만삭스는 최근 주식에 대해 <a href="https://www.benzinga.com/quote/SFM/analyst-ratings" target="_blank" rel="noopener">매수 등급을 유지</a>하고 목표 주가를 127달러에서 159달러로 상향 조정했다. 웰스 파고는 주식에 대해 중립 등급을 유지하고 목표 주가를 90달러에서 130달러로 상향 조정했다.
주식은 최근 5일 거래일 동안 11% 이상 상승했으며, 2024년 연초 대비 195% 이상 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135528/Screenshot-237.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
인튜이티브 서지컬 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>):
이 의료 기기 회사는 지난주 독자들 사이에서 강한 관심을 받았으며, 주가가 금요일에 52주 최고가로 거래되고 있다.
이 회사는 최근 <a href="https://kr.benzinga.com/news/usa/stocks/%EC%9D%B8%ED%8A%9C%EC%9D%B4%ED%8B%B0%EB%B8%8C-%EC%84%9C%EC%A7%80%EC%BB%AC%EC%9D%98-%EC%A3%BC%EC%8B%9D%EC%9D%80-%EA%B0%95%EB%A0%A5%ED%95%9C-3%EB%B6%84%EA%B8%B0-%EC%8B%A4%EC%A0%81%EC%97%90-%EC%8B%9C/" target="_blank" rel="noopener">3분기 재무 결과</a>를 발표했으며, 매출이 20억 4천만 달러로 컨센서스 예상치인 20억 달러를 초과했고, 주당 순이익이 1.84달러로 컨센서스 예상치인 1.63달러를 초과했다. 인튜이티브 서지컬은 3분기 동안 전년 대비 17%의 매출 성장을 보고했으며, 전 세계 다 빈치(da Vinci) 수술 건수가 전년 대비 18% 증가했다.
이 회사는 3분기 동안 379개의 다 빈치 시스템을 설치했으며, 이는 이전 분기의 312개에서 증가한 수치이다. 3분기 말 기준으로 설치된 다 빈치 수술 시스템은 9,539개이다. 인튜이티브는 10월에 한국에서 다 빈치 5 수술 시스템에 대한 규제 승인을 받았다.
이 실적 발표 이후 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406234/intuitive-surgical-posts-q3-earnings-beat-these-analysts-raise-forecasts-on-dv5-upt" target="_blank" rel="noopener" data-google-interstitial="false">여러 애널리스트들이 목표 주가를 상향</a> 조정했다. 애널리스트들은 회사의 최신 다 빈치 5 시스템이 더 많은 종류의 수술에 사용할 수 있어 성장 촉매제로 작용할 것으로 보고 있다. 인튜이티브 서지컬 주식은 최근 5일 거래일 동안 6.02% 상승했으며, 2024년 연초 대비 62.08% 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135542/Screenshot-238.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
뮬러 인더스트리즈 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>):
이 산업 회사는 트럼프의 2024년 대선 승리 가능성과 관련하여 증가한 관심과 주가 상승을 경험했다. 이 회사는 최근 3분기 순매출이 9억 9,780만 달러로 컨센서스 예상치인 9억 3,600만 달러를 초과했으며, 분기 주당 순이익이 1.48달러로 예상치인 1.32달러를 초과했다고 <a href="https://ir.muellerindustries.com/news/press-releases/detail/178/mueller-industries-inc-reports-third-quarter-2024-earnings" target="_blank" rel="noopener">발표</a>했다. 뮬러 인더스트리즈는 최근 인수한 사업과 분기 중 구리 가격 상승이 매출 성장에 기여했다고 밝혔다.
뮬러의 CEO인 그렉 크리스토퍼(Greg Christopher)는 &#8220;우리는 금리 인하와 인플레이션 완화, 선거 관련 불확실성의 해소가 더 안정적이고 유리한 환경을 만들어 줄 것으로 예상했다&#8221;고 말했다.
주식은 최근 5일 동안 15.89% 상승했으며, 2024년 연초 대비 102% 이상 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08135559/Screenshot-240.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
다음 주 보고서를 계속 지켜봐 주시기 바랍니다. 여기에서 Benzinga Pro를 팔로우하여 모든 최신 헤드라인과 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">시장을 움직이는 주요 스토리</a>를 확인하세요.
Photo: Benzinga
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Exclusives

INSM

벤징가의 '스톡 위스퍼' 지수: 인스메드, 인튜이티브 서지컬, 뮬러 인더스트리즈 및 2종목

인공지능(AI)을 테마로 한 상장지수펀드(ETF)는 자산 운용사들이 <a href="https://www.benzinga.com/topic/artificial-intelligence" target="_blank" rel="noopener" data-google-interstitial="false">인공지능</a>을 둘러싼 관심이 높아지는 것을 활용하면서 상당한 급증을 목격하고 있다. 모닝스타(Morningstar)에 따르면 올해 AI 중심 ETF 24개 중 1/3 이상이 출시되었다.
무슨 일이 (What Happened): 지난주에만 인공 지능에 초점을 맞추기 위해 브랜드가 변경된 ETF를 포함해 3개의 새로운 ETF가 AI 부문에 진출했다고 월요일 로이터가 보도했다. AI ETF의 총 자산은 현재 45억 달러에 이르렀으며, 이는 원자력 테마 ETF가 보유한 55억 달러에 근접하고 대마초 부문의 13억 7천만 달러를 넘어섰다.
모닝스타의 수석 분석가인 다니엘 소티로프(Daniel Sotiroff)는 &#8220;그들의 수가 증가하고 있는 것에 놀랍지 않다&#8221;고 언급하면서, 산업의 빠른 속도가 빠른 수익을 원하는 투자자들을 끌어들인다고 강조했다.
참고: <a href="https://kr.benzinga.com/news/usa/stocks/11%EC%9B%94-%EA%B8%88%EB%A6%AC-%EC%9D%B8%ED%95%98-%EA%B1%B0%EC%9D%98-%EA%B2%B0%EC%A0%95-%EC%97%B0%EC%A4%80%EC%9D%98-%EB%A7%88%EC%A7%80%EB%A7%89-%EA%B2%B0%EC%A0%95-%EC%9D%B4%ED%9B%84-%EA%B0%80/" target="_blank" rel="noopener">11월 금리 인하가 거의 확정된 상황: 최근 연준 결정 이후 가장 많이 상승한 10개 주식</a>
Benzinga Pro 데이터에 따르면, 지난 1년 동안 AI 기반 ETF의 성과는 다음과 같다:
Global X Robotics and Artificial Intelligence ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NASDAQ">BOTZ</a>): 현재 순자산 25억 1천만 달러, 순자산 가치(NAV)가 31.59달러인 BOTZ는 40.39% 상승했다. AI 관련 주요 보유 종목으로는 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)와 생명공학 회사 인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>)가 있다.
Global X Artificial Intelligence &amp; Technology ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NASDAQ">AIQ</a>): 순자산 22억 7,000만 달러, NAV가 37.36달러인 AIQ는 43.64% 상승했다. 오라클(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), 시스코 시스템즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>)및 메타 플랫폼스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)는 이 ETF의 최고 AI 관련 자산 중 일부이다.
iShares US Technology ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYW#NYSE">IYW</a>): IYW는 지난 1년 동안 50.72% 상승했다. 이 ETF는 155.42달러의 NAV와 192억 4천만 달러의 순자산을 보유하고 있으며, 애플(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), 엔비디아, 마이크로소프트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) 및 브로드컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)과 같은 기술 주식에도 투자할 수 있다. 이들 주식은 AI에 대한 관심 덕분에 눈부신 성장을 목격했다.
Fidelity MSCI Information Technology Index ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTEC#NYSE">FTEC</a>): 이 ETF는 48.55% 상승했으며, 애플, 마이크로소프트, 엔비디아, 알파벳 및 브로드컴과 같은 주식에 투자할 수 있다. 순자산은 120억 5천만 달러이다.
왜 중요한가 (Why It Matters): AI 테마 ETF의 급증은 인공지능 기술에 대한 수요 증가에 의해 주도되는 광범위한 추세의 일환이다. 최근 엔비디아가 잠시 애플을 제치고 <a href="https://www.benzinga.com/markets/equities/24/10/41551461/nvidia-overtakes-apple-as-worlds-most-valuable-company-again">세계에서 가장 가치 있는 회사</a>가 된 바 있다. 이는 AI 슈퍼컴퓨팅 칩에 대한 수요 증가에 의해 촉발된 것이다. 이는 기술 분야에서 AI의 중요성이 커지고 있음을 강조한다.
더욱이, <a href="https://www.benzinga.com/news/24/10/41351070/imf-warns-ai-in-stock-trading-can-boost-efficiency-but-warns-of-increased-market-volatility">국제통화기금</a>(IMF)는 AI가 시장 효율성을 높일 수 있는 잠재력을 가지고 있지만, 시장 변동성과 사이버 위협의 증가를 경고했다. IMF의 글로벌 금융 안정성 보고서는 AI 기반 거래가 시장을 혁신할 수 있다고 제안하지만, 그 채택은 여전히 제한적이라고 경고한다. 또한, 규제가 덜한 비은행 금융 중개 기관들로의 투자 이동 가능성에 대해 경고하여 시장 감독을 복잡하게 만들 수 있다.

다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41517027/five-us-banks-face-billions-in-losses-as-silvers-price-spike-hits-short-sellers-hard-report?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">5개 미국 은행, 은 가격 급등으로 공매도 투자자에게 타격: 수십억 달러 손실 직면</a></li>
</ul>
면책사항: 이 내용은 일부가 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>의 도움을 받아 작성되었으며, Benzinga 편집자에 의해 검토 및 게시되었습니다.
사진 제공: Unsplash
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Intuitive Surgical

뉴스

에 대한 최신 뉴스 Intuitive Surgical (NASDAQ:ISRG) 주식

월요일, 3월 10, 2025

월요일, 1월 27, 2025

금요일, 1월 24, 2025

목요일, 1월 16, 2025

목요일, 12월 12, 2024

토요일, 11월 09, 2024

월요일, 10월 28, 2024

목요일, 10월 17, 2024

목요일, 7월 25, 2024

금요일, 4월 19, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌